Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $4.4M | conv 52ClusterFirst in 12mo | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
KalVista Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |